Dexamphetamine normalises electrophysiological activity in attention deficit-hyperactivity disorder during the Stroop
S L Horrobin1, N A McNair, I J Kirk
1Department of Psychology, Research Centre for Cognitive Neuroscience, University of Auckland, Auckland, New Zealand.
Neurocase
|September 11, 2008
Summary
Dexamphetamine normalizes brain activity in adults with attention deficit/hyperactivity disorder (ADHD). This study shows improved interference control and electroencephalography patterns in ADHD patients when treated with dexamphetamine.
Area of Science:
- Neuroscience
- Clinical Psychology
- Pharmacology
Background:
- Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder.
- Interference control is often impaired in individuals with ADHD.
- Understanding medication effects on cognitive function is crucial for treatment.
Observation:
- A case study examined an adult with ADHD performing a Stroop task.
- Electroencephalography (EEG) and event-related potentials (ERPs) were recorded.
- EEG data were compared on and off dexamphetamine, with a matched control.
Findings:
- Individuals with ADHD off medication showed reversed ERP polarity to incongruent stimuli compared to controls.
- Dexamphetamine administration normalized the ERP response in the ADHD participant.
- This suggests dexamphetamine enhances interference control by normalizing neural activity.
Implications:
- Dexamphetamine may effectively improve cognitive control in adults with ADHD.
- EEG and ERPs can serve as biomarkers for treatment response.
- Further research is warranted to explore these findings in larger ADHD cohorts.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...